EGFR-mutant Non-small Cell Lung Cancer Accompanied by Transient Asymptomatic Pulmonary Opacities Successfully Treated with “Stop-And-Go” Osimertinib

A 69-year-old man with post-operative recurrence of lung adenocarcinoma was treated with multiple chemotherapies, including epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors. A second biopsy revealed an EGFR T790M mutation. As 10th-line chemotherapy, osimertinib was initiated. After...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Keigo, Naoki, Katsuhiko, Kuroda, Aoi, Yasuda, Hiroyuki, Kawada, Ichiro, Soejima, Kenzo, Betsuyaku, Tomoko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919862/
https://www.ncbi.nlm.nih.gov/pubmed/29269665
http://dx.doi.org/10.2169/internalmedicine.9609-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919862/
https://www.ncbi.nlm.nih.gov/pubmed/29269665
http://dx.doi.org/10.2169/internalmedicine.9609-17

Ejemplares similares